Sharmila Dissanaike - Sep 20, 2021 Form 3 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Sharmila Dissanaike
Stock symbol
HRTX
Transactions as of
Sep 20, 2021
Transactions value $
$0
Form type
3
Date filed
9/29/2021, 04:16 PM
Next filing
Dec 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HRTX Common Stock 6.25K Sep 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HRTX Stock Option (Right to Buy) Sep 20, 2021 Common Stock 37.5K $12.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning three months after the date of grant (09/20/2021).
F2 The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (09/20/2021).